Harrow, Inc. (HROW)

52.20 +0.20 (+0.38%) USD  |  NASDAQ  |  Feb 23, 10:07
More

Harrow Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Corcept Therapeutics, Inc. Upgrade
Assertio Holdings, Inc. Upgrade
CapsoVision, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade